Investigating the Level of MUC5B Expression in the Plasma of Patients with Idiopathic Pulmonary Fibrosis (IPF) Compared to Healthy Individuals

https://cmfrc.tums.ac.ir/article/Investigating-the-Level-of-MUC5B-Expression-in-the-Plasma-of-Patients-with-Idiopathic-Pulmonary-Fibrosis-(IPF)-Compared-to-Healthy-Individuals

Investigating the Level of MUC5B Expression in the Plasma of Patients with Idiopathic Pulmonary Fibrosis (IPF) Compared to Healthy Individuals Investigating the Level of MUC5B Expression in the Plasma of Patients with Idiopathic Pulmonary Fibrosis (IPF) Compared to Healthy Individuals --> Abstract Introduction: Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease associated with high morbidity and mortality. Genetic factors, particularly the MUC5B promoter polymorphism,